Marshall Wace’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Marshall Wace’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,000	Closed	-$110K	–	2558
2024 Q1	$110K	Hold	30,000	–	–	﹤0.01%	2301
2023 Q4	$106K	Sell	30,000 -7,722	-20%	-$2.2K	﹤0.01%	2038
2023 Q3	$97.7K	Sell	37,722 -42,278	-53%	-$19.9K	﹤0.01%	2048
2023 Q2	$315K	Sell	80,000 -120,000	-60%	-$53.7K	﹤0.01%	2126
2023 Q1	$676K	Hold	200,000	–	–	﹤0.01%	1978
2022 Q4	$716K	Sell	200,000 -214,666	-52%	-$137K	﹤0.01%	2219
2022 Q3	$1.67M	Hold	414,666	–	–	﹤0.01%	2129
2022 Q2	$1.85M	Hold	414,666	–	–	﹤0.01%	2056
2022 Q1	$3.52M	Hold	414,666	–	–	0.01%	1666
2021 Q4	$3.66M	Sell	414,666 -24,411	-6%	-$59.6K	0.01%	1610
2021 Q3	$4.57M	Buy	439,077 +72,411	+20%	+$151K	0.02%	983
2021 Q2	$3.85M	Buy	366,666 +4,936	+1%	+$10.8K	0.02%	1002
2021 Q1	$3.72M	Buy	361,730 +195,064	+117%	+$714K	0.02%	1005
2020 Q4	$1.85M	Buy	+166,666	New	+$219K	0.01%	979

Other funds holding SRTAW

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

TPCW

TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Marshall Wace's SRTAW Position: Q4 2020 in Review

Marshall Wace sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q4 2020, closing a stake of 166,666 shares — an estimated $219K sold.

Marshall Wace first reported a position in SRTAW in Q3 2020 and held it in 1 quarter. The position peaked at $203K in Q3 2020. 17 funds tracked by Wall St. Rank hold SRTAW as of Q4 2020.

Marshall Wace reported no remaining Strata Critical Medical Inc Warrants position as of Q4 2020 after selling out during the quarter.
Marshall Wace sold 166,666 Strata Critical Medical Inc Warrants shares in Q4 2020, an estimated $219K.
Marshall Wace first reported a position in Strata Critical Medical Inc Warrants in Q3 2020 and held it in 1 quarter.
Marshall Wace's Strata Critical Medical Inc Warrants position peaked at $203K in Q3 2020.
17 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q4 2020.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.